Loading...
XSHE002589
Market cap487mUSD
Jan 10, Last price  
2.71CNY
1D
-2.87%
1Q
-7.19%
Jan 2017
-80.40%
IPO
114.30%
Name

Realcan Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHE:002589 chart
P/E
175.83
P/S
0.44
EPS
0.02
Div Yield, %
0.00%
Shrs. gr., 5y
0.29%
Rev. gr., 5y
-25.03%
Revenues
8.03b
-34.74%
1,147,109,8081,601,730,8282,213,382,6633,195,448,0634,622,237,6185,925,841,6917,785,907,0779,749,957,91515,618,666,23723,293,620,46033,918,534,25635,258,509,45327,203,883,91521,059,718,89612,311,277,7538,034,367,997
Net income
20m
29,177,86244,757,33562,109,22284,057,346110,651,372143,554,930180,986,792235,938,544590,758,9431,368,455,7351,277,805,8600624,551,807382,013,017020,317,689
CFO
82m
-84.23%
061,384,54270,557,005000000002,094,524,875364,539,132442,952,611523,073,87482,466,692
Dividend
Jun 04, 20240.013 CNY/sh

Profile

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. It sells drugs, vaccines, and medical devices. The company also provides medical logistics services; third-party logistics services; disinfection and sterilization; and lease, and hospital logistics services for medical institutions. It serves drug distribution, academic services, medical diagnosis, financial technology, traditional Chinese medicine, digital medical care, professional logistics, and comprehensive equipment. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.
URL
https://www.realcan.cn/
IPO date
Jun 10, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
8,034,368
-34.74%
12,311,278
-41.54%
Cost of revenue
7,683,152
11,813,719
Unusual Expense (Income)
NOPBT
351,216
497,558
NOPBT Margin
4.37%
4.04%
Operating Taxes
(167,389)
Tax Rate
NOPAT
518,605
497,558
Net income
20,318
 
Dividends
(13,269)
Dividend yield
0.22%
Proceeds from repurchase of equity
(28,540)
BB yield
0.58%
Debt
Debt current
6,556,061
3,848,167
Long-term debt
262,945
72,661
Deferred revenue
1,934
Other long-term liabilities
1,619
1
Net debt
906,192
(3,107,542)
Cash flow
Cash from operating activities
82,467
523,074
CAPEX
(298,384)
Cash from investing activities
579,530
592,957
Cash from financing activities
(677,197)
FCF
(1,749,685)
4,494,459
Balance
Cash
5,060,787
5,340,212
Long term investments
852,029
1,688,157
Excess cash
5,511,097
6,412,805
Stockholders' equity
2,245,625
2,360,455
Invested Capital
10,211,143
7,282,650
ROIC
5.93%
6.23%
ROCE
2.81%
5.14%
EV
Common stock shares outstanding
1,505,014
1,474,312
Price
3.27
-20.63%
4.12
5.07%
Market cap
4,921,396
-18.98%
6,074,166
5.07%
EV
6,016,771
3,310,644
EBITDA
570,897
781,440
EV/EBITDA
10.54
4.24
Interest
323,351
407,706
Interest/NOPBT
92.07%
81.94%